Elanco Animal Health Incorporated ELAN
26.48 USD -0.28 (-1.05%)
At closeNov 11, 2026, 4:00 PM EST
26.46 -0.02 -0.06%
After hours · Nov 11, 4:00 PM ET
26.14 Day range 26.76
19.40 52-week range 27.98
- YTD
- +17.01%
- 1 year
- +15.84%
News
seekingalpha.com Elanco Animal Health Incorporated (ELAN) Presents at 2026 UBS Global Healthcare Conference Transcript Elanco Animal Health Incorporated ( ELAN ) 2026 UBS Global Healthcare Conference November 9, 2026 1:15 PM EST Company Participants Robert VanHimbergen - Executive VP & CFO Rajeev Modi - Executive…
benzinga.com JP Morgan Maintains Overweight on Elanco Animal Health, Raises Price Target to $35 JP Morgan analyst Chris Schott maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $33 to $35.
fool.com Elanco Animal Health: 3 Key Takeaways for Long-Term Investors Third-quarter organic constant currency revenue grew 9% year over year. Elanco Animal Health lowered gross debt by $216 million in Q3.
marketbeat.com Elanco Animal Health Q3 Earnings Call Highlights Elanco Animal Health NYSE: ELAN raised its full-year outlook after third-quarter revenue rose 11%, driven by demand for its pet health products Zenrelia and Credelio Quattro and higher prices across…
seekingalpha.com Elanco Animal Health Incorporated (ELAN) Q3 2026 Earnings Call Transcript Elanco Animal Health Incorporated ( ELAN ) Q3 2026 Earnings Call November 6, 2026 8:00 AM EST Company Participants Tiffany Kanaga - VP of Investor Relations & ESG Jeffrey Simmons - President, CEO &…
benzinga.com Elanco Animal Health Sees Strong Momentum Heading Into 2027 Elanco Animal Health Incorporated (NYSE:ELAN) delivered better-than-expected third-quarter financial results on strong demand and higher prices.
benzinga.com Elanco Animal Health Sees Strong Momentum Heading Into 2027 Elanco Animal Health beats Q3 earnings and revenue estimates, driven by Pet Health demand and pricing gains, while raising its full-year 2026 outlook.
zacks.com Elanco Animal Health (ELAN) Reports Q3 Earnings: What Key Metrics Have to Say The headline numbers for Elanco Animal Health (ELAN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to…
benzinga.com Elanco Animal Health Q3 2026 Earnings Call Transcript Elanco Animal Health (NYSE:ELAN) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
zacks.com Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.19 per share a…
benzinga.com Elanco Animal Health Sees Q4 Adj EPS $0.16-$0.19 vs $0.18 Est; Sees Sales $1.190B-$1.215B vs $1.193B Est Elanco Animal Health (NYSE:ELAN) is looking for Q4 Adj EPS of $0.16-$0.19 vs $0.18 analyst estimate. sees sales of $1.190 billion-$1.215 billion vs $1.193 billion analyst estimate.- benzinga.com Elanco Animal Health Raises FY2026 Adj EPS Guidance from $1.10-$1.16 to $1.17-$1.20 vs $1.13 Est; Raises FY2026 Sales Guidance from $5.090B-$5.140B to $5.155B-$5.180B vs $5.132B Est Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.10-$1.16 to $1.17-$1.20 vs $1.13 analyst estimate. Raises FY2026 sales outlook from $5.090 billion-$5.140 billion to $5.155…
benzinga.com Elanco Animal Health Q3 Adj. EPS $0.27 Beats $0.20 Estimate, Sales $1.265B Beat $1.208B Estimate Elanco Animal Health (NYSE:ELAN) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.20 by 35 percent. This is a 42.11 percent increase over earnings of…
prnewswire.com Elanco Animal Health Reports Third Quarter 2026 Results Accelerated Price, Organic Constant Currency Revenue Growth, and Gross Margin Expansion; Raising Full Year Outlook and Innovation Target; Achieved 2.9x Net Leverage Ratio Milestone Third Quarter 2026…
prnewswire.com October Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority Latest U.S. Survey of 2,000+ Consumers Shows 93% of Pet Owners Maintained or Increased Pet Spending in Past Three Months, Omnichannel Shift Redefines Purchasing INDIANAPOLIS, Nov. 6, 2026…
benzinga.com Enbridge, Moderna On Deck Friday As Demand, Vaccine Pipeline Face Test Enbridge headlines Friday’s reports, with investors weighing whether resilient pipeline utilization can offset a softer revenue comparison. Moderna, Brookfield Asset Management, Humana, Vistra, PPL,…
247wallst.com Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch One stock has soared more than sevenfold this year, another just lost a quarter of its value on leaked data, and a third carries the fate of millions of retirees. Friday's earnings could test each…- benzinga.com Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Lowers Price Target to $25 Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Equal-Weight and lowers the price target from $26 to $25.
benzinga.com This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday Analysts downgraded Qiagen, Alcoa and Dutch Bros, cutting price targets for Qiagen to $52 and Dutch Bros to $46.
benzinga.com This Chipotle Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday Wall Street analysts downgraded Accenture, Braze, Chipotle, SmartFinancial and more, with several price-target cuts.
benzinga.com Occidental Petroleum To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Tuesday Analysts cut targets for WING, ELAN, SBAC and RH; raised targets for TRV, OXY and GILD, with ELAN downgraded to Hold.
benzinga.com This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday Analysts downgraded Werner, Zoetis, Apple, Heartland Express and Elanco, cutting ratings to Neutral/Hold and lowering price targets.- benzinga.com Jefferies Downgrades Elanco Animal Health to Hold, Lowers Price Target to $24 Jefferies analyst Keith Devas downgrades Elanco Animal Health (NYSE:ELAN) from Buy to Hold and lowers the price target from $31 to $24.
benzinga.com This Urban Outfitters Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Analysts initiated coverage: ELAN Buy/$32, IRTC Overweight/$160, BAND Equal-Weight/$56, HRTG Market Perform, and URBN Buy/$100.- benzinga.com Goldman Sachs Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $32 Goldman Sachs analyst Matt Dellatorre initiates coverage on Elanco Animal Health (NYSE:ELAN) with a Buy rating and announces Price Target of $32.